Phenotypes associated with this allele
neoplasm
|
• mice exhibit similar tumorigenesis as Atmintm1.1Jhh/Atmintm1.1Jhh Tg(Fcer2a-cre)5Mbu mice
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Atmintm1.1Jhh mutation
(2 available);
any
Atmin mutation
(38 available)
Tg(Fcer2a-cre)5Mbu mutation
(4 available)
|
|
|
hematopoietic system
N |
• mice exhibit normal B cell numbers in the spleen and antigen-specific IgG1-switched antibodies
|
neoplasm
N |
• mice repeatedly immunized with sheep red blood cells do not exhibit an increase in tumor-related death
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hdac1tm1.1Pmt mutation
(0 available);
any
Hdac1 mutation
(36 available)
Hdac2tm1.1Pmt mutation
(0 available);
any
Hdac2 mutation
(38 available)
Tg(Fcer2a-cre)5Mbu mutation
(4 available)
|
|
|
immune system
|
• massive induction of apoptosis is detected when cells are cultured with LPS and IL4 or anti-IgM Fab
|
|
• fail to proliferate in response to LPS and IL4 or anti-IgM Fab fragment stimulation
|
hematopoietic system
|
• massive induction of apoptosis is detected when cells are cultured with LPS and IL4 or anti-IgM Fab
|
|
• fail to proliferate in response to LPS and IL4 or anti-IgM Fab fragment stimulation
|
cellular
|
• massive induction of apoptosis is detected when cells are cultured with LPS and IL4 or anti-IgM Fab
|
|
• fail to proliferate in response to LPS and IL4 or anti-IgM Fab fragment stimulation
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3tm1.2Mbu mutation
(0 available);
any
Tcf3 mutation
(39 available)
Tcf3tm1Mbu mutation
(1 available);
any
Tcf3 mutation
(39 available)
Tg(Fcer2a-cre)5Mbu mutation
(4 available)
|
|
|
immune system
N |
• despite reduced B cell numbers, class switching, NP-specific production of IgG1, IgG2a and IgG3, B cell proliferation, memory B cells and plasma B cells following stimulation are normal following immunization
|
|
• splenic B cell numbers are minimally reduced compared to in wild-type mice
|
|
• 8 days following immunization, PNA+ germinal center number and size are reduced compared to in wild-type or heterozygous mice
• however, stimulated germinal B cell proliferation is normal
|
|
• at 4 and 8 days after immunization germinal center B cell numbers are 3- to 5-fold lower tan in wild-type or heterozygous mice
|
hematopoietic system
|
• splenic B cell numbers are minimally reduced compared to in wild-type mice
|
|
• at 4 and 8 days after immunization germinal center B cell numbers are 3- to 5-fold lower tan in wild-type or heterozygous mice
|
|
• 8 days following immunization, PNA+ germinal center number and size are reduced compared to in wild-type or heterozygous mice
• however, stimulated germinal B cell proliferation is normal
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nfatc1tm1Rao mutation
(0 available);
any
Nfatc1 mutation
(47 available)
Tg(Fcer2a-cre)5Mbu mutation
(4 available)
|
|
|
immune system
|
• stimulated B cells exhibit reduced ability to induced T cell proliferation
|
|
• alpha-IgM-mediated
• however, LPS-stimulated B cell proliferation is normal
|
|
• to IgG3 induced by T cell-independent type II antigens
|
|
• after immunization with NP-KLH
|
|
• 10-fold after immunization with NP-Ficoll
|
|
• after immunization with NP-Ficoll
|
|
• in unstimulated B cells
|
|
• from LPS-stimulated B cells
|
|
• from stimulated B cells
|
hematopoietic system
|
• stimulated B cells exhibit reduced ability to induced T cell proliferation
|
|
• alpha-IgM-mediated
• however, LPS-stimulated B cell proliferation is normal
|
|
• to IgG3 induced by T cell-independent type II antigens
|
|
• after immunization with NP-KLH
|
|
• 10-fold after immunization with NP-Ficoll
|
|
• after immunization with NP-Ficoll
|
|
• in unstimulated B cells
|
cellular
|
• alpha-IgM-mediated
• however, LPS-stimulated B cell proliferation is normal
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rtcbtm1c(KOMP)Wtsi mutation
(0 available);
any
Rtcb mutation
(25 available)
Tg(Fcer2a-cre)5Mbu mutation
(4 available)
|
|
|
immune system
|
• slight decrease in the percentage of CD138+ CD22- plasmablasts in cells stimulated with LPS in vitro
|
|
• plasmablasts have disorganized and less dense ER structures
|
|
• impaired ability of plasma cells to secrete immunoglobins
|
|
• in culture supernatants of pre-plasmablasts and plasmablasts
• however, the number of plasmablasts secreting IgM is similar to control cultures
|
hematopoietic system
|
• slight decrease in the percentage of CD138+ CD22- plasmablasts in cells stimulated with LPS in vitro
|
|
• plasmablasts have disorganized and less dense ER structures
|
|
• impaired ability of plasma cells to secrete immunoglobins
|
|
• in culture supernatants of pre-plasmablasts and plasmablasts
• however, the number of plasmablasts secreting IgM is similar to control cultures
|